Raderer M, Vorbeck F, Formanek M, Osterreicher C, Valencak J, Penz M, Kornek G, Hamilton G, Dragosics B, Chott A
Department of Internal Medicine I, University of Vienna, Austria.
Br J Cancer. 2000 Aug;83(4):454-7. doi: 10.1054/bjoc.2000.1308.
Lymphoma of the mucosa-associated lymphoid tissue (MALT) type usually arises in MALT acquired through chronic antigenic stimulation triggered by persistent infection and/or autoimmune processes. Due to specific ligand-receptor interactions between lymphoid cells and high-endothelial venules of MALT, both normal and neoplastic lymphoid cells display a pronounced homing tendency to MALT throughout the body. In the case of neoplastic disease these homing properties may be responsible for lymphoma dissemination among various MALT-sites. According to this concept, we have standardized staging procedures in all patients diagnosed with MALT-type lymphoma. All patients with MALT-type lymphoma underwent standardized staging procedures before treatment. Staging included ophthalmologic examination, otolaryngologic investigation, gastroscopy with multiple biopsies, endosonography of the upper gastrointestinal tract, enteroclysis, colonoscopy, computed tomography of thorax and abdomen and bone marrow biopsy. Biopsy was performed in all lesions suggestive for lymphomatous involvement, and evaluation of all biopsy specimens was performed by a reference pathologist. 35 consecutive patients with histologically verified MALT-type lymphoma were admitted to our department. Twenty-four patients (68%) had primary involvement of the stomach, five (15%) had lymphoma of the ocular adnexa, three (8.5%) had lymphoma of the parotid, and three (8,5%) of the lung. Lymph-node involvement corresponding to stage EII disease was found in 13 patients (37%), only one patient with primary gastric lymphoma had local and supradiaphragmatic lymph-node involvement (stage EIII). Bone marrow biopsies were negative in all patients. Overall, eight of 35 patients (23%) had simultaneous biopsy-proven involvement of two MALT-sites: one patient each had lymphoma of parotid and lacrimal gland, conjunctiva and hypopharynx, conjunctiva and skin, lacrimal gland and lung, stomach and colon, and stomach and lung. The remaining two patients had bilateral parotideal lymphoma. Staging work-up was negative for lymph-node involvement in all of these eight patients. The importance of extensive staging in MALT-type lymphoma is emphasized by the demonstration of multiorgan involvement in almost a quarter of patients. In addition, our data suggest that extra-gastrointestinal MALT-type lymphoma more frequently occurs simultaneously at different anatomic sites than MALT-type lymphoma involving the GI-tract.
黏膜相关淋巴组织(MALT)型淋巴瘤通常发生于因持续感染和/或自身免疫过程引发的慢性抗原刺激所获得的MALT中。由于淋巴样细胞与MALT的高内皮微静脉之间存在特定的配体-受体相互作用,正常和肿瘤性淋巴样细胞在全身均表现出对MALT明显的归巢倾向。在肿瘤性疾病中,这些归巢特性可能是淋巴瘤在不同MALT部位播散的原因。根据这一概念,我们对所有诊断为MALT型淋巴瘤的患者的分期程序进行了标准化。所有MALT型淋巴瘤患者在治疗前均接受了标准化分期程序。分期包括眼科检查、耳鼻喉科检查、多次活检的胃镜检查、上消化道内镜超声检查、小肠灌肠造影、结肠镜检查、胸部和腹部计算机断层扫描以及骨髓活检。对所有提示淋巴瘤累及的病变进行活检,并由一名参考病理学家对所有活检标本进行评估。35例经组织学证实为MALT型淋巴瘤的患者被收入我科。24例患者(68%)为胃部原发性受累,5例(15%)为眼附属器淋巴瘤,3例(8.5%)为腮腺淋巴瘤,3例(8.5%)为肺部淋巴瘤。13例患者(37%)发现有符合EII期疾病的淋巴结受累,仅1例原发性胃淋巴瘤患者有局部和膈上淋巴结受累(EIII期)。所有患者的骨髓活检均为阴性。总体而言,35例患者中有8例(23%)同时经活检证实有两个MALT部位受累:分别为1例腮腺和泪腺淋巴瘤、1例结膜和下咽淋巴瘤、1例结膜和皮肤淋巴瘤、1例泪腺和肺部淋巴瘤、1例胃和结肠淋巴瘤以及1例胃和肺部淋巴瘤。其余2例患者为双侧腮腺淋巴瘤。这8例患者的分期检查均未发现淋巴结受累。几乎四分之一的患者出现多器官受累,这突出了MALT型淋巴瘤广泛分期的重要性。此外,我们的数据表明,与累及胃肠道的MALT型淋巴瘤相比,胃肠道外MALT型淋巴瘤更常同时发生于不同解剖部位。